PCVX Insider Trading Activity and SEC Form 4 Filings
PCVX insider trading summary
Over the past 12 months, insiders at Vaxcyte, Inc. (PCVX) reported 37 sales worth $9.5M by 5 insiders and no open-market purchases on SEC Form 4. Net insider selling was $9.5M.
Latest PCVX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 2, 2026 | Jim Wassil | EVP, Chief Scientific Ofc, COO | Sell | $21K (343 @ $61.57) |
| Nov 2, 2026 | Elvia Cowan | SVP, Finance & CAO | Sell | $147K (2,414 @ $60.77) |
| Nov 2, 2026 | Elvia Cowan | SVP, Finance & CAO | Sell | $36K (586 @ $61.55) |
| Nov 2, 2026 | Jim Wassil | EVP, Chief Scientific Ofc, COO | Sell | $116K (1,907 @ $60.78) |
| Oct 5, 2026 | Jim Wassil | EVP, Chief Scientific Ofc, COO | Sell | $1.6M (18,000 @ $86.74) |
| Oct 5, 2026 | Elvia Cowan | SVP, Finance & CAO | Sell | $1.6M (19,000 @ $86.74) |
| Oct 1, 2026 | Jim Wassil | EVP, Chief Scientific Ofc, COO | Sell | $122K (2,155 @ $56.65) |
| Oct 1, 2026 | Jim Wassil | EVP, Chief Scientific Ofc, COO | Sell | $5K (95 @ $57.09) |
| Sep 1, 2026 | Jim Wassil | Chief Operating Officer | Sell | $19K (303 @ $61.42) |
| Sep 1, 2026 | Jim Wassil | Chief Operating Officer | Sell | $94K (1,537 @ $60.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.